This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

J.P. Morgan Reaffirms Their Hold Rating on Medtronic (MDT)

Tipranks - Tipranks - Sun Jun 7, 7:40AM CDT

J.P. Morgan analyst Robbie Marcus maintained a Hold rating on Medtronic yesterday and set a price target of $86.00. The company’s shares closed yesterday at $81.67.

Claim 55% Off TipRanks

Marcus covers the Healthcare sector, focusing on stocks such as Boston Scientific, Cooper Co, and HeartFlow, Inc.. According to TipRanks, Marcus has an average return of 6.6% and a 50.70% success rate on recommended stocks.

Medtronic has an analyst consensus of Moderate Buy, with a price target consensus of $98.52, representing a 20.63% upside. In a report released on June 4, Robert W. Baird also maintained a Hold rating on the stock with a $85.00 price target.

See Insiders’ Hot Stocks on TipRanks >>

Based on Medtronic’s latest earnings release for the quarter ending January 23, the company reported a quarterly revenue of $9.02 billion and a net profit of $1.14 billion. In comparison, last year the company earned a revenue of $8.29 billion and had a net profit of $1.29 billion

Read More on MDT:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).